Medtech has announced the sale of thirteen new Rosa robots during the fourth fiscal quarter 2016 (April 1 to June 30, 2016).
Of the thirteen robots, seven were sold in the USA, two in France, two in China, one in Germany, and one in the UK. In comparison, ten robots were sold during the same period in the previous year. For fiscal year 2016 (July 1, 2015 to June 30, 2016), Medtech sold 33 Rosa robots, compared to 20 in the previous year.
Bertin Nahum, chief executive officer and founder of Medtech, says, “We continue to make steady progress in our growth strategy, as evidenced by these thirteen new Rosa sales during the fiscal fourth quarter. The results also demonstrate the broad global market potential for Rosa across North America, Europe and Asia, and our ability to execute in each of these regions.”
The sales made in fourth quarter 2016 were as follows:
- One Rosa robot was sold to the University of Minnesota Medical Center (Minneapolis.
- A second robot was sold to the Children’s National Health System (Washington, DC.
- A third robot was sold to Children’s Minnesota (St Paul).
- A fourth robot was sold to UMass Memorial Medical Center (Worcester, Massachusetts), a pioneering hospital in the field of neurosurgery with the development of minimally invasive surgery techniques.
- A fifth robot was sold to University of Pittsburgh Medical Center (Pittsburg).
- A sixth robot was sold to Duke University Hospital (Durham, North Carolina).
- A seventh robot was sold to Florida Hospital (Orlando).
- One Rosa robot was sold to Rennes University Hospital (Rennes).
- A second Rosa was sold to Kremlin-Bicêtre Hospital (Paris).
Two additional sales of the Rosa robot were made in China. With these two new sales, Medtech now has 11 Rosa robots in China.
- One Rosa robot was sold to Uniklinik Köln, a university hospital in Cologne.
- In the UK, a robot was sold to the Royal Hallamshire Hospital (Sheffield).